The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Amoxicillin Market Research Report 2024
Synopsis
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
The global Amoxicillin market was valued at US$ 4613 million in 2023 and is anticipated to reach US$ 5812.3 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.
This report aims to provide a comprehensive presentation of the global market for Amoxicillin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amoxicillin.
Report Scope
The Amoxicillin market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amoxicillin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amoxicillin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Segment by Type
Capsule
Tablet
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amoxicillin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
The global Amoxicillin market was valued at US$ 4613 million in 2023 and is anticipated to reach US$ 5812.3 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.
This report aims to provide a comprehensive presentation of the global market for Amoxicillin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amoxicillin.
Report Scope
The Amoxicillin market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amoxicillin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amoxicillin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Segment by Type
Capsule
Tablet
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amoxicillin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Amoxicillin Market Overview
1.1 Product Overview and Scope of Amoxicillin
1.2 Amoxicillin Segment by Type
1.2.1 Global Amoxicillin Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Others
1.3 Amoxicillin Segment by Application
1.3.1 Global Amoxicillin Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Amoxicillin Market Size Estimates and Forecasts
1.4.1 Global Amoxicillin Revenue 2019-2030
1.4.2 Global Amoxicillin Sales 2019-2030
1.4.3 Global Amoxicillin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amoxicillin Market Competition by Manufacturers
2.1 Global Amoxicillin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amoxicillin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amoxicillin Average Price by Manufacturers (2019-2024)
2.4 Global Amoxicillin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amoxicillin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amoxicillin, Product Type & Application
2.7 Amoxicillin Market Competitive Situation and Trends
2.7.1 Amoxicillin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amoxicillin Players Market Share by Revenue
2.7.3 Global Amoxicillin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amoxicillin Retrospective Market Scenario by Region
3.1 Global Amoxicillin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amoxicillin Global Amoxicillin Sales by Region: 2019-2030
3.2.1 Global Amoxicillin Sales by Region: 2019-2024
3.2.2 Global Amoxicillin Sales by Region: 2025-2030
3.3 Global Amoxicillin Global Amoxicillin Revenue by Region: 2019-2030
3.3.1 Global Amoxicillin Revenue by Region: 2019-2024
3.3.2 Global Amoxicillin Revenue by Region: 2025-2030
3.4 North America Amoxicillin Market Facts & Figures by Country
3.4.1 North America Amoxicillin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amoxicillin Sales by Country (2019-2030)
3.4.3 North America Amoxicillin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amoxicillin Market Facts & Figures by Country
3.5.1 Europe Amoxicillin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amoxicillin Sales by Country (2019-2030)
3.5.3 Europe Amoxicillin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amoxicillin Market Facts & Figures by Country
3.6.1 Asia Pacific Amoxicillin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amoxicillin Sales by Country (2019-2030)
3.6.3 Asia Pacific Amoxicillin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amoxicillin Market Facts & Figures by Country
3.7.1 Latin America Amoxicillin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amoxicillin Sales by Country (2019-2030)
3.7.3 Latin America Amoxicillin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amoxicillin Market Facts & Figures by Country
3.8.1 Middle East and Africa Amoxicillin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amoxicillin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amoxicillin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amoxicillin Sales by Type (2019-2030)
4.1.1 Global Amoxicillin Sales by Type (2019-2024)
4.1.2 Global Amoxicillin Sales by Type (2025-2030)
4.1.3 Global Amoxicillin Sales Market Share by Type (2019-2030)
4.2 Global Amoxicillin Revenue by Type (2019-2030)
4.2.1 Global Amoxicillin Revenue by Type (2019-2024)
4.2.2 Global Amoxicillin Revenue by Type (2025-2030)
4.2.3 Global Amoxicillin Revenue Market Share by Type (2019-2030)
4.3 Global Amoxicillin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amoxicillin Sales by Application (2019-2030)
5.1.1 Global Amoxicillin Sales by Application (2019-2024)
5.1.2 Global Amoxicillin Sales by Application (2025-2030)
5.1.3 Global Amoxicillin Sales Market Share by Application (2019-2030)
5.2 Global Amoxicillin Revenue by Application (2019-2030)
5.2.1 Global Amoxicillin Revenue by Application (2019-2024)
5.2.2 Global Amoxicillin Revenue by Application (2025-2030)
5.2.3 Global Amoxicillin Revenue Market Share by Application (2019-2030)
5.3 Global Amoxicillin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Amoxicillin Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Amoxicillin Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Centrient Pharma
6.3.1 Centrient Pharma Corporation Information
6.3.2 Centrient Pharma Description and Business Overview
6.3.3 Centrient Pharma Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Centrient Pharma Amoxicillin Product Portfolio
6.3.5 Centrient Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Amoxicillin Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Amoxicillin Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Amoxicillin Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 NCPC
6.6.1 NCPC Corporation Information
6.6.2 NCPC Description and Business Overview
6.6.3 NCPC Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NCPC Amoxicillin Product Portfolio
6.7.5 NCPC Recent Developments/Updates
6.8 United Laboratories
6.8.1 United Laboratories Corporation Information
6.8.2 United Laboratories Description and Business Overview
6.8.3 United Laboratories Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 United Laboratories Amoxicillin Product Portfolio
6.8.5 United Laboratories Recent Developments/Updates
6.9 Sun Pharma
6.9.1 Sun Pharma Corporation Information
6.9.2 Sun Pharma Description and Business Overview
6.9.3 Sun Pharma Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sun Pharma Amoxicillin Product Portfolio
6.9.5 Sun Pharma Recent Developments/Updates
6.10 CSPC
6.10.1 CSPC Corporation Information
6.10.2 CSPC Description and Business Overview
6.10.3 CSPC Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CSPC Amoxicillin Product Portfolio
6.10.5 CSPC Recent Developments/Updates
6.11 LKPC
6.11.1 LKPC Corporation Information
6.11.2 LKPC Amoxicillin Description and Business Overview
6.11.3 LKPC Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 LKPC Amoxicillin Product Portfolio
6.11.5 LKPC Recent Developments/Updates
6.12 Hikma
6.12.1 Hikma Corporation Information
6.12.2 Hikma Amoxicillin Description and Business Overview
6.12.3 Hikma Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hikma Amoxicillin Product Portfolio
6.12.5 Hikma Recent Developments/Updates
6.13 Dr. Reddy
6.13.1 Dr. Reddy Corporation Information
6.13.2 Dr. Reddy Amoxicillin Description and Business Overview
6.13.3 Dr. Reddy Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dr. Reddy Amoxicillin Product Portfolio
6.13.5 Dr. Reddy Recent Developments/Updates
6.14 HPGC
6.14.1 HPGC Corporation Information
6.14.2 HPGC Amoxicillin Description and Business Overview
6.14.3 HPGC Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HPGC Amoxicillin Product Portfolio
6.14.5 HPGC Recent Developments/Updates
6.15 Aurubindo
6.15.1 Aurubindo Corporation Information
6.15.2 Aurubindo Amoxicillin Description and Business Overview
6.15.3 Aurubindo Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Aurubindo Amoxicillin Product Portfolio
6.15.5 Aurubindo Recent Developments/Updates
6.16 Meiji Holdings
6.16.1 Meiji Holdings Corporation Information
6.16.2 Meiji Holdings Amoxicillin Description and Business Overview
6.16.3 Meiji Holdings Amoxicillin Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Meiji Holdings Amoxicillin Product Portfolio
6.16.5 Meiji Holdings Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amoxicillin Industry Chain Analysis
7.2 Amoxicillin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amoxicillin Production Mode & Process
7.4 Amoxicillin Sales and Marketing
7.4.1 Amoxicillin Sales Channels
7.4.2 Amoxicillin Distributors
7.5 Amoxicillin Customers
8 Amoxicillin Market Dynamics
8.1 Amoxicillin Industry Trends
8.2 Amoxicillin Market Drivers
8.3 Amoxicillin Market Challenges
8.4 Amoxicillin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
